SLE,cold anitibody mediated haemolysis with Pseudohyperkalaemia

  • Mushtaq Ahmad Department of Rheumatology, SKIMS
  • Fayaz Ahmad Sofi Department of Rhematology, SKIMS
  • Muzafar Bashir Mir Department of Rhematology,SKIMS
DOI: https://doi.org/10.33883/jms.v23i4.806
Keywords: SLE, Pseudohyperkalaemia

Abstract

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease of unknown etiology that can potentially affect any organ system of the body. The most common hematologic manifestations of SLE include anemia, leukopenia, thrombocytopenia, lymphadenopathy, and/or splenomegaly. Anemia occurs in around 50% of patients with SLE and the most common type of anemia is that of chronic disease. Autoimmune hemolytic anemia (AIHA) has been reported in up to 10 percent of SLE patients1-3. Autoantibodies to RBCs in SLE may be warm- or cold-reactive; however, warm autoimmune hemolysis is much more common. Only few cases of cold-antobody mediated hemolysis are reported in published literature till date4, 5, 11.

Downloads

Download data is not yet available.

Author Biographies

Mushtaq Ahmad, Department of Rheumatology, SKIMS

MD, Additional Professor

Fayaz Ahmad Sofi, Department of Rhematology, SKIMS

M.D, Professor

Muzafar Bashir Mir, Department of Rhematology,SKIMS

Senior Resident

References

1. Giannouli S, Voulgarelis M, Ziakas PD, Tzioufas AG. Anaemia in systemic lupus erythematosus: from pathophysiology to clinical assessment. Ann Rheum Dis 2006; 65:144.
2. Bhatt AS, Berliner N. Hematologic Manifestations of SLE. In: Lupus Erythematosus: Clinical Evaluation and Treatment, Schur P, Massarotti E (Eds), Springer, New York 2012. p.127-140.
3. Keeling DM, Isenberg DA. Haematological manifestations of systemic lupus erythematosus. Blood Rev 1993; 7:199.
4. Chaubey VK, Chhabra L. Cold agglutinin-induced haemolysis in association with antinuclear antibody-negative SLE. BMJ Case Rep. 2013;2013:bcr2013009337. Published 2013 Jun 10. doi:10.1136/bcr-2013-009337.
5. Srinivasan N, Oswal A, Garg S, Nahar J, Gosmonova A, Nahar R. Cold agglutinin induced hemolysis in a newly diagnosed systemic lupus erythematosus. Am J Med Sci. 2010;339(3):270-273. doi:10.1097/MAJ.0b013e3181ac3bd5
6. Kokori SI, Ioannidis JP, Voulgarelis M, et al. Autoimmune hemolytic anemia in patients with systemic lupus erythematosus. Am J Med 2000; 108:198.
7. Barcellini W. New insights in the pathogenesis of autoimmune hemolytic anemia. Transfus Med Hemother. 2015;42:287–93.
8. Gehrs BC, Friedberg RC. Autoimmune hemolytic anemia. Am J Hematol. 2002;69:258–71.
9. Gertz MA. Cold agglutinin disease. Haematologica. 2006;91:439–41.
10. Michel M. Classification and therapeutic approaches in autoimmune hemolytic anemia: An update. Expert Rev Hematol. 2011; 4:607–18.
11. Mohanty B, Ansari MZ, Kumari P, Sunder A. Cold agglutinin-induced hemolytic anemia as the primary presentation in SLE - A case report. J Family Med Prim Care. 2019;8(5):1807-1808. doi:10.4103/jfmpc.jfmpc_298_19.
Published
2021-01-19
How to Cite
1.
Ahmad M, Sofi FA, Mir MB. SLE,cold anitibody mediated haemolysis with Pseudohyperkalaemia. jms [Internet]. 2021Jan.19 [cited 2026Oct.4];23(4):35-7. Available from: https://old.jmsskims.org/index.php/jms/article/view/806
Issue
Vol 23 No 4 (2020): Oct-Dec
Section
Case Reports
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Most read articles by the same author(s)